Evidence map›Paper›PMID 39936918›Full record

ArticleJournal of virology2025

Plus-strand RNA viruses hijack Musashi homolog 1 to shield viral RNA from cytoplasmic ribonuclease degradation.

Defang Zhou, Menglu Xu, Qingjie Liu, Ruixue Xin, Gege Cui, Longying Ding, Xiaoyang Liu, Xinyue Zhang, Tianxing Yan, Jing Zhou and 4 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Defang ZhouCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.ORCID 0000-0002-9380-0079
Menglu XuCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Qingjie LiuCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Ruixue XinCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Gege CuiCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Longying DingCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Xiaoyang LiuCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Xinyue ZhangCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Tianxing YanCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Jing ZhouCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.
Shuhai HeCollege of Animal Science and Technology, Xinyang Agriculture and Forestry University, Xinyang, Henan, China.
Liangyu YangCollege of Veterinary Medicine, Yunnan Agricultural University, Kunming, Yunnan, China.
Bin XiangCollege of Veterinary Medicine, Yunnan Agricultural University, Kunming, Yunnan, China.
Ziqiang ChengCollege of Veterinary Medicine, Shandong Agricultural University, Tai'an, Shandong, China.ORCID 0000-0003-4323-2541

Funding

| Natural Science Foundation of Shandong Province () ZR2023MC214the Key R & D Program of Shandong Province 2023CXGC010704the Shandong Modern Agricultural Technology & Industry System No. SDAIT-11-04
6 · The paper itself

Abstract

A successful strategy employed by RNA viruses to achieve replication is to evade host cell RNase degradation. However, the mechanisms through which plus-strand RNA viruses effectively shield viral RNA from cellular ribonuclease degradation remain unclear. In this study, we identified the phenomenon whereby plus-strand RNA viruses, including avian leukosis virus subgroup J (ALV-J), reticuloendotheliosis virus (REV), chicken astrovirus (CAstV), and porcine epidemic diarrhea virus (PEDV), hijacked host cellular Musashi homolog 1 (MSI1). These viruses upregulated MSI1 expression and facilitated its translocation from the cytoplasmic periphery to a position proximal to and within the nucleus, thereby protecting viral RNA from degradation. Mechanistic analyses revealed that these viruses use distinct regions, the unique (U3) region or three prime untranslated region (3'UTR), to engage with MSI1, consequently shielding their viral RNA from cytoplasmic ribonuclease degradation. These results offer significant implications for understanding the replication tactics used by plus-strand RNA viruses, thereby advancing our understanding of their biological behaviors.IMPORTANCEThe intricate interplay between RNA viruses and host cell RNA regulation encompasses viral mechanisms designed to circumvent RNase-mediated degradation. However, the specific strategies employed by plus-strand RNA viruses to shield their RNA from host ribonucleases remain inadequately characterized. In this study, Musashi homolog 1 (MSI1) is predominantly localized in the cytoplasm of normal cells, distinct from the nucleus. Following infection by plus-strand RNA viruses such as avian leukosis virus subgroup J (ALV-J), reticuloendotheliosis virus (REV), chicken astrovirus (CAstV), and porcine epidemic diarrhea virus (PEDV), these viruses hijack MSI1 to relocate near and within the nucleus. This hijacking is facilitated by specific regions, including unique or three prime untranslated regions, thereby preventing viral RNA from degradation by cytoplasmic ribonucleases. These findings have significant implications for elucidating the replication strategies of plus-strand RNA viruses, thereby advancing our understanding of their biological mechanisms.

Indexed as

RibonucleasesRNA-Binding ProteinsRNA, ViralRNA VirusesAnimalsCytoplasmHumansRNA StabilityVirus ReplicationRibonucleasesRNA-Binding ProteinsRNA, ViralMSI1plus-strand RNA virusribonucleaseRNA-binding proteinviral RNA degradation

Identifiers

PMID39936918
PMCPMC11915826

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.